{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:13:02Z","timestamp":1786360382362,"version":"build-2736575974"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022Y5C7KL"],"award-info":[{"award-number":["2022Y5C7KL"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["PNRR M4C2-Investimento 1.4-CN00000041"],"award-info":[{"award-number":["PNRR M4C2-Investimento 1.4-CN00000041"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"publisher","award":["P-DiSC BATT-BIRD2023-UNIPD"],"award-info":[{"award-number":["P-DiSC BATT-BIRD2023-UNIPD"]}],"id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2025.2604232","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:49:08Z","timestamp":1767376148000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Insights into the complexity of SARS-CoV-2 M\n                    <sup>pro<\/sup>\n                    inhibition: Ebselen and its derivatives impair dimerisation of the enzyme"],"prefix":"10.1080","volume":"41","author":[{"given":"Simone","family":"Fabbian","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fabi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurin","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Preto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Schiavinato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Salata","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Crocetti","sequence":"additional","affiliation":[{"name":"NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Florence","place":["Sesto Fiorentino, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Battistutta","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gatto","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Sosic","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"1251705","DOI":"10.3389\/fmicb.2023.1251705","article-title":"Characterization of host substrates of SARS-CoV-2 main protease","volume":"14","author":"Melano I","year":"2023","unstructured":"Melano I, Lo YC, Su WC. Characterization of host substrates of SARS-CoV-2 main protease. Front Microbiol. 2023;14:1251705.","journal-title":"Front Microbiol"},{"issue":"4","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.3390\/ijms24043236","article-title":"Identification of SARS-CoV-2 Main Protease (Mpro) cleavage sites using two-dimensional electrophoresis and in silico cleavage site prediction","volume":"24","author":"Miltner N","year":"2023","unstructured":"Miltner N, Kall\u00f3 G, Cs\u0151sz \u00c9, Miczi M, Nagy T, Mahdi M, M\u00f3ty\u00e1n JA, T\u0151zs\u00e9r J. Identification of SARS-CoV-2 Main Protease (Mpro) cleavage sites using two-dimensional electrophoresis and in silico cleavage site prediction. Int J Mol Sci. 2023;24(4):3236.","journal-title":"Int J Mol Sci"},{"issue":"17","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich S","year":"2020","unstructured":"Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020;30(17):127377.","journal-title":"Bioorg Med Chem Lett"},{"issue":"6489","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang L","year":"2020","unstructured":"Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368(6489):409\u2013412.","journal-title":"Science"},{"issue":"4","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"e0209421","DOI":"10.1128\/mBio.02094-21","article-title":"Regulation of the dimerization and activity of SARS-CoV-2 main protease through reversible glutathionylation of Cysteine 300","volume":"12","author":"Davis DA","year":"2021","unstructured":"Davis DA, Bulut H, Shrestha P, Yaparla A, Jaeger HK, Hattori SI, Wingfield PT, Mieyal JJ, Mitsuya H, Yarchoan R. Regulation of the dimerization and activity of SARS-CoV-2 main protease through reversible glutathionylation of Cysteine 300. mBio. 2021;12(4):e0209421.","journal-title":"mBio"},{"issue":"1","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s42003-022-03084-7","article-title":"Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor","volume":"5","author":"Nashed NT","year":"2022","unstructured":"Nashed NT, Aniana A, Ghirlando R, Chiliveri SC, Louis JM. Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor. Commun Biol. 2022;5(1):160.","journal-title":"Commun Biol"},{"issue":"1","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"e14425","DOI":"10.1111\/cbdd.14425","article-title":"Progress of SARS-CoV-2 main protease peptide-like inhibitors","volume":"103","author":"Liu X","year":"2024","unstructured":"Liu X, Ren X, Hua M, Liu F, Ren X, Sui C, Li Q, Luo F, Jiang Z, Xia Z, et al. Progress of SARS-CoV-2 main protease peptide-like inhibitors. Chem Biol Drug Des. 2024;103(1):e14425.","journal-title":"Chem Biol Drug Des"},{"issue":"6575","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen DR","year":"2021","unstructured":"Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, et al. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374(6575):1586\u20131593.","journal-title":"Science"},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"118247","DOI":"10.1016\/j.bmc.2025.118247","article-title":"Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 M(pro) from 2022 to 2024","volume":"128","author":"Braconi L","year":"2025","unstructured":"Braconi L, Sosic A, Crocetti L. Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 M(pro) from 2022 to 2024. Bioorg Med Chem. 2025;128:118247.","journal-title":"Bioorg Med Chem"},{"issue":"6497","key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai W","year":"2020","unstructured":"Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science. 2020;368(6497):1331\u20131335.","journal-title":"Science"},{"issue":"52","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"23544","DOI":"10.1002\/anie.202010316","article-title":"Allosteric inhibition of the SARS\u2010CoV\u20102 main protease: insights from mass spectrometry based assays**","volume":"59","author":"El\u2010Baba TJ","year":"2020","unstructured":"El\u2010Baba TJ, Lutomski CA, Kantsadi AL, Malla TR, John T, Mikhailov V, Bolla JR, Schofield CJ, Zitzmann N, Vakonakis I, et al. Allosteric inhibition of the SARS\u2010CoV\u20102 main protease: insights from mass spectrometry based assays**. Angew Chem Int Ed. 2020;59(52):23544\u201323548.","journal-title":"Angew Chem Int Ed"},{"issue":"6542","key":"e_1_3_4_13_1","first-page":"642","article-title":"X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease","volume":"372","author":"G\u00fcnther S","year":"2021","unstructured":"G\u00fcnther S, Reinke PYA, Fern\u00e1ndez-Garc\u00eda Y, Lieske J, Lane TJ, Ginn HM, Koua FHM, Ehrt C, Ewert W, Oberthuer D, et al. X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease. Science (1979). 2021;372(6542):642\u2013646.","journal-title":"Science (1979)"},{"key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"116704","DOI":"10.1016\/j.ejmech.2024.116704","article-title":"Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: insights into their design, classification, biological activity, and binding interactions","volume":"277","author":"Shawky AM","year":"2024","unstructured":"Shawky AM, Almalki FA, Alzahrani HA, Abdalla AN, Youssif BGM, Ibrahim NA, Gamal M, El-Sherief HAM, Abdel-Fattah MM, Hefny AA, et al. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: insights into their design, classification, biological activity, and binding interactions. Eur J Med Chem. 2024;277:116704.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1021\/cr0406559","article-title":"Organoselenium and organotellurium compounds: toxicology and pharmacology","volume":"104","author":"Nogueira CW","year":"2004","unstructured":"Nogueira CW, Zeni G, Rocha JB. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev. 2004;104(12):6255\u20136285.","journal-title":"Chem Rev"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.freeradbiomed.2020.06.032","article-title":"Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections","volume":"156","author":"Sies H","year":"2020","unstructured":"Sies H, Parnham MJ. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic Biol Med. 2020;156:107\u2013112.","journal-title":"Free Radic Biol Med"},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijsu.2020.10.018","article-title":"Ebselen, a new candidate therapeutic against SARS-CoV-2","volume":"84","author":"Haritha CV","year":"2020","unstructured":"Haritha CV, Sharun K, Jose B. Ebselen, a new candidate therapeutic against SARS-CoV-2. Int J Surg. 2020;84:53\u201356.","journal-title":"Int J Surg"},{"issue":"1","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-021-23313-7","article-title":"Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives","volume":"12","author":"Amporndanai K","year":"2021","unstructured":"Amporndanai K, Meng X, Shang W, Jin Z, Rogers M, Zhao Y, Rao Z, Liu Z-J, Yang H, Zhang L, et al. Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nat Commun. 2021;12(1):3061.","journal-title":"Nat Commun"},{"issue":"4","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1021\/acs.jmedchem.1c00566","article-title":"Discovery and mechanism of SARS-CoV-2 main protease inhibitors","volume":"65","author":"Huff S","year":"2022","unstructured":"Huff S, Kummetha IR, Tiwari SK, Huante MB, Clark AE, Wang S, Bray W, Smith D, Carlin AF, Endsley M, et al. Discovery and mechanism of SARS-CoV-2 main protease inhibitors. J Med Chem. 2022;65(4):2866\u20132879.","journal-title":"J Med Chem"},{"issue":"7811","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin Z","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289\u2013293.","journal-title":"Nature"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"117531","DOI":"10.1016\/j.bmc.2023.117531","article-title":"Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: design, synthesis, biological evaluation, and structure-activity relationships exploration","volume":"96","author":"Zhang H","year":"2023","unstructured":"Zhang H, Li J, Toth K, Tollefson AE, Jing L, Gao S, Liu X, Zhan P. Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: design, synthesis, biological evaluation, and structure-activity relationships exploration. Bioorg Med Chem. 2023;96:117531.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1039\/D3MD00736G","article-title":"Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity","volume":"15","author":"Crocetti L","year":"2024","unstructured":"Crocetti L, Catarzi F, Giovannoni MP, Vergelli C, Bartolucci G, Pallecchi M, Paoli P, Rossi P, Lippi M, Schepetkin IA, et al. Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity. RSC Med Chem. 2024;15(4):1247\u20131257.","journal-title":"RSC Med Chem"},{"issue":"9","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge M","year":"2020","unstructured":"Laforge M, Elbim C, Fr\u00e8re C, H\u00e9madi M, Massaad C, Nuss P, Benoliel J-J, Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515\u2013516.","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.12688\/f1000research.7931.1","article-title":"FreeSASA: an open source C library for solvent accessible surface area calculations","volume":"5","author":"Mitternacht S.","year":"2016","unstructured":"Mitternacht S. FreeSASA: an open source C library for solvent accessible surface area calculations. F1000Res. 2016;5:189.","journal-title":"F1000Res"},{"issue":"3","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjae004","article-title":"Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern","volume":"16","author":"Frasson I","year":"2024","unstructured":"Frasson I, Diamante L, Zangrossi M, Carbognin E, Piet\u00e0 AD, Penna A, Rosato A, Verin R, Torrigiani F, Salata C, et al. Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern. J Mol Cell Biol. 2024;16(3).","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1038\/s41598-023-35907-w","article-title":"Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase","volume":"13","author":"Zmudzinski M","year":"2023","unstructured":"Zmudzinski M, Rut W, Olech K, Granda J, Giurg M, Burda-Grabowska M, Kaleta R, Zgarbova M, Kasprzyk R, Zhang L, et al. Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase. Sci Rep. 2023;13(1):9161.","journal-title":"Sci Rep"},{"issue":"16","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1021\/ac1011602","article-title":"Study of highly selective and efficient thiol derivatization using selenium reagents by mass spectrometry","volume":"82","author":"Xu K","year":"2010","unstructured":"Xu K, Zhang Y, Tang B, Laskin J, Roach PJ, Chen H. Study of highly selective and efficient thiol derivatization using selenium reagents by mass spectrometry. Anal Chem. 2010;82(16):6926\u20136932.","journal-title":"Anal Chem"},{"issue":"13","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1039\/D1SC05892D","article-title":"Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation","volume":"13","author":"El Khoury L","year":"2022","unstructured":"El Khoury L, Jing Z, Cuzzolin A, Deplano A, Loco D, Sattarov B, H\u00e9din F, Wendeborn S, Ho C, El Ahdab D, et al. Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation. Chem Sci. 2022;13(13):3674\u20133687.","journal-title":"Chem Sci"},{"issue":"4","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"e202100582","DOI":"10.1002\/cmdc.202100582","article-title":"Structure-activity studies reveal scope for optimisation of Ebselen-type inhibition of SARS-CoV-2 Main Protease","volume":"17","author":"Thun-Hohenstein STD","year":"2022","unstructured":"Thun-Hohenstein STD, Suits TF, Malla TR, Tumber A, Brewitz L, Choudhry H, Salah E, Schofield CJ. Structure-activity studies reveal scope for optimisation of Ebselen-type inhibition of SARS-CoV-2 Main Protease. ChemMedChem. 2022;17(4):e202100582.","journal-title":"ChemMedChem"},{"issue":"3","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (M(pro)): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu Q","year":"2022","unstructured":"Hu Q, Xiong Y, Zhu GH, Zhang YN, Zhang YW, Huang P, Ge GB. The SARS-CoV-2 main protease (M(pro)): structure, function, and emerging therapies for COVID-19. MedComm (2020). 2022;3(3):e151.","journal-title":"MedComm (2020)"},{"issue":"26","key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/jcc.26717","article-title":"Identification of novel inhibitors of SARS-CoV-2 main protease (Mpro) from Withania sp. by molecular docking and molecular dynamics simulation","volume":"42","author":"Verma S","year":"2021","unstructured":"Verma S, Patel CN, Chandra M. Identification of novel inhibitors of SARS-CoV-2 main protease (Mpro) from Withania sp. by molecular docking and molecular dynamics simulation. J Comput Chem. 2021;42(26):1861\u20131872.","journal-title":"J Comput Chem"},{"issue":"1","key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s42003-024-07138-w","article-title":"Allostery in homodimeric SARS-CoV-2 main protease","volume":"7","author":"Fornasier E","year":"2024","unstructured":"Fornasier E, Fabbian S, Shehi H, Enderle J, Gatto B, Volpin D, Biondi B, Bellanda M, Giachin G, Sosic A, et al. Allostery in homodimeric SARS-CoV-2 main protease. Commun Biol. 2024;7(1):1435.","journal-title":"Commun Biol"},{"issue":"37","key":"e_1_3_4_33_1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd0345","article-title":"Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease","volume":"6","author":"Men\u00e9ndez CA","year":"2020","unstructured":"Men\u00e9ndez CA, Byl\u00e9hn F, Perez-Lemus GR, Alvarado W, de Pablo JJ. Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease. Sci Adv. 2020;6(37).","journal-title":"Sci Adv"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"105455","DOI":"10.1016\/j.bioorg.2021.105455","article-title":"The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus","volume":"117","author":"Qiao Z","year":"2021","unstructured":"Qiao Z, Wei N, Jin L, Zhang H, Luo J, Zhang Y, Wang K. The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus. Bioorg Chem. 2021;117:105455.","journal-title":"Bioorg Chem"},{"issue":"1","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"pgae578","DOI":"10.1093\/pnasnexus\/pgae578","article-title":"An orally available P1\u2019-5-fluorinated M(pro) inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier","volume":"4","author":"Higashi-Kuwata N","year":"2025","unstructured":"Higashi-Kuwata N, Bulut H, Hayashi H, Tsuji K, Ogata-Aoki H, Kiso M, Takamune N, Kishimoto N, Hattori SI, Ishii T, et al. An orally available P1\u2019-5-fluorinated M(pro) inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier. PNAS Nexus. 2025;4(1):pgae578.","journal-title":"PNAS Nexus"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2604232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:49:12Z","timestamp":1767376152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2025.2604232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2025.2604232"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2025.2604232","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2604232"}}